Jazz Pharmaceuticals plc

Historical 13F Holders

Symbol
JAZZ
CUSIP
G50871105
All holders as of
Q2 2026
Type
Equity
Class
SHS USD
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for G50871105 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G
7.4% 8/6/2026
Event 6/30/2026
Vanguard Capital Management LLC 13G 5.0% 4/30/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 56 639 k $145 M
2026 Q2 673 80.1 M $15.6 B
2026 Q1 602 65.1 M $12.3 B
2025 Q4 611 63.4 M $10.8 B
2025 Q3 528 62.6 M $8.25 B
2025 Q2 522 62.2 M $6.60 B
2025 Q1 577 60.1 M $7.45 B
2024 Q4 528 59.3 M $7.29 B
2024 Q3 496 59.6 M $6.64 B
2024 Q2 475 59.8 M $6.38 B
2024 Q1 512 61.3 M $7.37 B
2023 Q4 530 59.6 M $7.33 B
2023 Q3 515 56.7 M $7.34 B
2023 Q2 490 56.8 M $7.05 B
2023 Q1 497 57.7 M $8.37 B
2022 Q4 513 58.6 M $9.34 B
2022 Q3 499 58.4 M $7.78 B
2022 Q2 491 58.0 M $9.01 B
2022 Q1 492 57.3 M $8.92 B
2021 Q4 488 57.9 M $7.39 B
2021 Q3 487 57.1 M $7.43 B
2021 Q2 539 57.8 M $10.3 B
2021 Q1 481 53.3 M $8.75 B
2020 Q4 466 53.9 M $8.93 B
2020 Q3 423 54.7 M $7.80 B
2020 Q2 414 52.5 M $5.78 B
2020 Q1 435 50.4 M $5.03 B
2019 Q4 482 54.4 M $8.11 B
2019 Q3 433 51.3 M $6.57 B
2019 Q2 458 50.9 M $7.25 B
2019 Q1 458 51.7 M $7.38 B
2018 Q4 445 54.4 M $6.72 B
2018 Q3 438 58.5 M $9.82 B
2018 Q2 411 61.5 M $10.6 B
2018 Q1 348 54.1 M $8.16 B
2017 Q4 350 55.5 M $7.37 B
2017 Q3 335 54.9 M $8.03 B
2017 Q2 349 53.4 M $8.31 B
2017 Q1 336 52.7 M $7.64 B
2016 Q4 330 52.5 M $5.72 B
2016 Q3 359 53.8 M $6.51 B
2016 Q2 395 53.9 M $11.2 B
2016 Q1 367 54.6 M $7.12 B
2015 Q4 380 56.8 M $7.97 B
2015 Q3 387 57.5 M $7.63 B
2015 Q2 392 56.0 M $9.86 B
2015 Q1 376 52.5 M $9.07 B
2014 Q4 384 54.8 M $8.99 B
2014 Q3 347 53.3 M $8.57 B
2014 Q2 329 51.3 M $7.55 B
2014 Q1 340 50.5 M $7.01 B